clinical trial · NCT01625897
A Long-Term Study of MP-214 in Patients With Chronic Phase or Elderly Schizophrenia
SchizophreniaMP-214Risperidone
brief summary
The objective of this study is to evaluate the long-term safety, tolerability, and efficacy of MP-214 in patients with chronic phase or elderly schizophrenia.
started
May 1, 2012
primary completion
Mar 1, 2015
completion
Mar 1, 2015
last updated
Jan 5, 2026
official title
A Long-term Study of MP-214 in Patients With Chronic Phase or Elderly Schizophrenia
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol